SWAY MEDICAL, INC. — Department of Defense SBIR Phase I: AF212-CSO1
SWAY MEDICAL, INC. — SBIR Phase I award from Department of Defense.
Phase I SBIR feasibility signal
- Phase I awards fund proof-of-concept work. For capture teams, they mark early interest from Department of Defense in a technical approach.
- Watch for Phase II follow-ons from the same firm/topic family — that conversion path is where budgets and transition pressure rise.
- Obligated amount $49,005. Cross-check similar awards in the same agency and technology tags for going-rate context.
- Topic code AF212-CSO1 links this award to a solicitation family — search the same topic stem for incumbents and recompete timing.
- Amount
- $49,005
- Agency
- Department of Defense · Air Force
- Program / Phase
- SBIR · Phase I
- Topic
- AF212-CSO1
- Solicitation
- X21.2
- NAICS
- —
- Place of performance
- OK
- Period
- 2021-12-06 → 2022-03-09
Description
Sway Medical, Inc. has developed scientifically validated, reliable, and FDA-approved mobile-based cognitive and balance assessments currently used commercially by clinicians screening for conditions such as mild traumatic brain injury, mild cognitive imp